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Abstract
Background: Mutations in pre-mRNA splicing factor PRPF31 can lead to retinitis pigmentosa (RP). Although the
exact disease mechanism remains unknown, it has been hypothesized that haploinsufficiency might be involved in
the pathophysiology of the disease.
Methods: In this study, we have analyzed a mouse model containing the p.A216P mutation in Prpf31 gene.
Results: We found that mutant Prpf31 protein produces cytoplasmic aggregates in the retinal pigment epithelium
and decreasing the protein levels of this splicing factor in the nucleus. Additionally, normal protein was recruited in
insoluble aggregates when the mutant protein was overexpressed in vitro. In response to protein aggregation,
Hspa4l is overexpressed. This member of the HSP70 family of chaperones might contribute to the correct folding
and solubilization of the mutant protein, allowing its translocation to the nucleus.
Conclusions: Our data suggests that a mechanism haploinsufficiency and dominant-negative is involved in retinal
degeneration due to mutations in PRPF31. HSP70 over-expression might be a new therapeutic target for the
treatment of retinal degeneration due to PRPF31 mutations.
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Background
Retinitis pigmentosa (RP) is one of a diverse group of ret-
inal dystrophies and one of the commonest causes of inher-
ited blindness in adults, affecting around 1:4000 individuals
worldwide (Verbakel et al., 2018). RP initially presents a
progressive impairment and cell death of rod photorecep-
tors, followed by loss of cones and retinal pigment
epithelium (RPE). Clinically, RP is characterized by
night blindness, which usually starts during adoles-
cence and progresses with constriction of the visual
field and a marked reduction in the amplitude of
electroretinogram (ERG) waves. So far, mutations in
more than 80 genes have been implicated in non-
syndromic RP (Verbakel et al., 2018). Many of these
genes encode for retinal-specific proteins; however,
some are ubiquitously expressed, such as splicing fac-
tors PRPF3, PRPF4, PRPF6, PRPF8 and PRPF31 (Liu
& Zack, 2013; Ruzickova & Stanek, 2017).
Pre-mRNA splicing is a general cellular function cru-
cial for the expression of eukaryotic transcripts. It is cat-
alyzed by the spliceosome, a large ribonucleoprotein
complex composed of five small nuclear ribonucleopro-
tein complexes (Ruzickova & Stanek, 2017). In humans,
PRPF31 encodes the homolog of S. cerevisiae pre-
mRNA processing factor 31, also known as PRPF31
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protein (Vithana et al., 2001). PRPF31 is required for
the U4/U6-U5 tri-snRNP formation and spliceosome
activity (Makarova et al., 2002; Schaffert et al., 2004).
Mutations in PRPF31 have been described as the sec-
ond most common cause of autosomal dominant RP
(adRP) known as RP11 (Vithana et al., 2001; Al-
Maghtheh et al., 1998; Rose et al., 2016) and, al-
though PRPF31 is necessary for pre-mRNA splicing in
every cell, adRP is the only clinical entity associated
with these mutations.
Curiously, within the PRPF31-affected families, it is
common to find asymptomatic carriers due to overex-
pression of the WT allele inherited from the normal par-
ent. Therefore, the differential expression of the WT
allele explains the incomplete penetrance associated with
this RP locus (Rose et al., 2016; Vithana et al., 2003). It
has recently been described that the expression level of
PRPF31 is regulated by the number of copies of a minis-
atellite repeat element-MSR1 located 200 bp upstream of
the promoter. High-expressing WT alleles are found in
asymptomatic carriers and low-expressing alleles are as-
sociated with the disease, where the amount of WT
PRPF31 protein produced is beneath its threshold for
normal function (Rose et al., 2016).
Although haploinsufficiency contributes to the physio-
pathology of the disease, it is still not clear how retinal
degeneration occurs in patients carrying PRPF31 muta-
tions. To explore disease mechanisms, two animal
models were previously generated (Bujakowska et al.,
2009). One was a heterozygous knockout (KO) mouse
(Prpf31+/−) and the second a knock-in (KI) mouse carry-
ing the point mutation p.A216P (Prpf31A216P/+). This
mutation was previously identified in RP11 patients with
a severe retinal phenotype (Vithana et al., 2001). How-
ever, both heterozygous mouse models did not show any
sign of photoreceptor degeneration and, as expected, the
homozygous mutant mice were found to be embryonic
lethal (Bujakowska et al., 2009). Based on these results, it
was speculated that Prpf31 is essential for survival and
the presence of one WT Prpf31 allele is enough to main-
tain retinal function with no dominant-negative effect of
the p.A216P mutation in mice.
More recently, it has been published that three
splicing-factor mouse models (Prpf3T494M/+,
Prpf8H2309P/+ and Prpf31+/−) develop late-onset morpho-
logical changes and dysfunction in the RPE rather than
photoreceptor degeneration (Farkas et al., 2014; Graziotto
et al., 2011). Therefore, in this work, we decided to study
the effect of the p.A216P mutation on RPE. We found
mislocalization and aggregation of the mutant Prpf31 pro-
tein with concomitant depletion of normal protein. These
results indicate mixed haploinsufficiency and dominant-
negative mechanisms involved in retinal degeneration due
to mutations in PRPF31. Also, this work postulates HSP70
modulation as a new therapeutic target for the treatment
of RP due to PRPF31mutations.
Methods
Animal handling and eye samples
Eight to sixteen-month old C57BL/6 J Prpf31+/+ (WT)
and C57BL/6 J Prpf31A216P/+ (KI) mice were housed in
the Biological Resources Unit of CABIMER and kept in
a temperature-controlled environment (21 ± 1 °C), with a
relative humidity of 55 ± 5%, a light/dark cycle 08:00–20:
00 and given standard mouse chow and water ad libi-
tum. Mouse genotyping was performed as previously de-
scribed (Bujakowska et al., 2009). Due to homozygous
Prpf31A216P/A216P mice are not viable, we use
Prpf31A216P/+ and Prpf31+/+ mice to obtain a similar pro-
portion of KI and WT in each litter. The WT mice used
as controls in each experiment belonged to the same lit-
ter of the Prpf31A216P/+ mice. The rd8 mutants were dis-
carded in these mice using the specific primers: forward
5′-GCC CCT GTT TGC ATG GAG GAA ACT TGG
AAG ACA GTC ACA GTT CTT CTG-3′ and reverse
5′-GCC CCA TTT GCA CAC TGA TGA C-3’ (Matta-
pallil et al., 2012). A group of WT CD-1 mice were also
used for the immunohistochemistry experiments.
All experiments described in this work were per-
formed in compliance with the Spanish and European
Laboratory Animal Science Association-FELASA Guide
for the Care and Use of Laboratory Animals, the Euro-
pean Union Council Directive 2010/63/EU for the use of
animals and the Association for Research in Vision and
Ophthalmology-ARVO for the use of animals in oph-
thalmic and vision research. Animal manipulation and
experimental methods have been approved by the Ethics
Committee for Animal Experimentation of CABIMER,
Seville, Spain. All efforts were made to minimize the
number of animals used and their suffering. Pig and cow
eye samples were obtained from a local slaughterhouse.
Human eye sample for Western blotting was obtained
from a deceased healthy donor, in a procedure approved




Immunohistochemistry was performed to evaluate distri-
bution of Prpf31 protein in retinal sections of WT CD-1
mice. The animals were euthanized by cervical disloca-
tion and the eyes excised quickly and fixed in ice-cold
4% paraformaldehyde (PFA) in PBS, overnight, at 4 °C.
The fixed eyes were then cryoprotected in 30% sucrose
in PBS, and embedded in optimal cutting temperature
compound for cryotome sections. Serial sections of
18 μm thick were mounted in five parallel series and
processed for immunohistochemistry. Briefly, the retinal
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sections were kept in 3% H2O2 in PBS for 30 min. Sam-
ples were then washed in 0.2% Triton X-100/PBS (PBS-
T) and blocked in 1% BSA/PBS-T at room temperature
for 1 h. Incubation with the primary antibody goat anti-
PRPF31 (1:100; OriGene Technologies Inc., Maryland,
USA, TA302582) and mouse anti-Rhodopsin (1:1000;
Abcam, Cambridge, UK, ab190307) were performed
overnight at 4 °C. After incubation, samples were washed
3 times in PBS-T, and incubated with appropriate bio-
tinylated anti-goat IgG (1:500; Vector Laboratories, Cali-
fornia, USA, BA9500) and anti-mouse IgG (1:250;
Chemicon International, California, USA, AP124B) anti-
bodies for 1 h at room temperature. The retinal sections
were incubated for 1 h in avidin-biotin-peroxidase com-
plex (1:500; Vector Laboratories). The immuno-reactive
signals were visualized by 0.02% 3,3′-diaminobenzidine,
0.4% nickel ammonium sulphate and 0.005% H2O2 in
50 nM Tris-HCl buffer. Standard haematoxylin staining
was performed in order to observe cell nuclei in the ret-
inal samples. Finally, samples were dehydrated and
mounted with Eukitt mounting medium (Sigma-Aldrich,
Missouri, USA).
Immunofluorescence experiments were performed on
eyecup sections obtained from WT and Prpf31A216P/+
mice. Serial sections of 18 μm thick were mounted in
five parallel series and processed for immunofluores-
cence. After 4% PFA fixation and cryopreservation, ret-
inal sections were incubated overnight at 4 °C with the
primary antibodies: goat anti-PRPF31 (1:100; OriGene
Technologies Inc., TA302582), mouse anti-RPE65 (1:
100; Abcam, ab78036), rabbit anti-Laminin (1:250;
Sigma-Aldrich, L9393), mouse anti-HSPA4L (1:100;
Santa Cruz Biotechnology, California, USA, SC-137007)
and rabbit anti-HSP27 (1:1000 Enzo Life Sciences, New
York, USA, ADI-SPA-803). After incubation, samples
were washed 3 times in 0.2% PBS-T, and incubated with
appropriate AlexaFluor® secondary antibodies (Molecular
Probes, Oregon, USA) at room temperature for 1 h.
After 3 washes, sections were mounted with Vectashield
mounting medium containing DAPI (Vector Laborator-
ies). Sections of all analysed cases were processed in par-
allel following an identical protocol without the
incubation step with the primary antibody, to be used as
controls for immunoreaction specificity. To detect chol-
esterol accumulation, retinal sections were incubated
with Filipin III (Sigma-Aldrich) for 2 h at room
temperature. Whole mount of the RPE was performed
as usually, and F-actin was stained with TRITC-
phalloidin (Sigma-Aldrich) according to the manufac-
turer’s instructions.
Immunofluorescence experiments were also performed
in cells grown on glass coverslips. Cells were fixed in 4%
PFA and then permeabilized and blocked with 2% don-
key serum/PBS-T for 1 h at room temperature.
Incubation with primary antibodies: goat anti-PRPF31
(1:100; OriGene Technologies Inc., TA302582) and
mouse anti-HSP70 (1:100; Santa Cruz Biotechnology,
SC-24) was performed for 1 h at room temperature.
Cells were washed three times with PBS-T and incu-
bated with AlexaFluor® secondary antibodies (Molecular
Probes). Coverslips were mounted on glass slides with
Vectashield mounting medium containing DAPI (Vector
Laboratories). Confocal images of retinal sections and
cell coverslips were captured by a spectral confocal
microscope TCS SP5 (Leica, Wetzlar, Germany) with an
HCX PL APO Lambda blue 63 1.4 OIL objective, at
22 °C. MetaMorph Microscopy Automation and Image
Analysis Software were used to analyse the images, and
quantification of colocalization signal was obtained using
Mander’s overlap coefficient. Adobe Photoshop CS5.1
software was used for digital amplification of the images.
Lipofuscin staining
Retinal sections were incubated with carbol-fuchsine so-
lution (4 g of fuchsine; 8 g of phenol, 20 mL of absolute
ethanol and 100 mL of distilled water), for 1 h at room
temperature. After 3 washes with distilled water, slides
were cleared with alcohol acid solution (1% hydrochloric
acid in 70% ethanol). The slides were then washed with
tap water for 5 min and counterstained with 2% picric
acid. Finally, slides were dehydrated with rising alcohol
solutions and cleared with xylene.
Transmission electron microscopy (TEM) images
Mice were anesthetized by subcutaneous injection of
ketamine hydrochloride/xylazine solution (80/12 mg/kg
body weight) and perfused using a fixation solution con-
taining 2.5% of PFA and 2.5% of glutaraldehyde in PBS.
Eyes were enucleated and fixed overnight at 4 °C in the
same fixation solution. TEM was performed by Nanoi-
maging Service in BIONAND (Malaga, Spain), using a
FEI Tecnai G2 29 TWIN Transmission Electron
Microscope.
Dissection of mouse neuroretina and RPE for protein and
mRNA extractions
The animals were euthanized by cervical dislocation and
the eyes quickly excised. The cornea was cut towards
corneal limbus, using a small spring scissor. Then, the
back of the eye was gently pressed to remove the lens.
Four cuts were made perpendicular to the corneal lim-
bus and towards the optic nerve head. The eye was
opened in four petals, and finally the neuroretina was
carefully separated from the underlying RPE-choroid
using curved forceps. Samples were collected in separate
microcentrifuge tubes for subsequent protein or mRNA
extraction.
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Western blot
Proteins were extracted in ice-cold RIPA buffer containing
protease inhibitor cocktail. Soluble/insoluble fractioning
was performed as previously described (Diaz-Corrales
et al., 2005). Briefly, cell lysates were incubated on ice for
60min and the homogenates were centrifuged (19,200×g,
20min at 4 °C). The supernatants (detergent-soluble frac-
tion) were collected and the pellets (detergent-insoluble
fraction) were re-suspended in resuspension buffer (60
mM Tris-HCl, 2% SDS, 2.5% 2-mercaptoethanol) and son-
icated for 20min, at 4 °C. Nuclear and cytosolic fractions
were collected using the Ne-Per Nuclear and Cytoplasmic
extraction reagents (Thermo Fisher Scientific). Protein
content was measured by DC™ protein assay (Bio-Rad,
California, USA) and samples stored at − 80 °C. Thirty mi-
crograms of each extract were separated in a denaturing
10% SDS–PAGE gel and the proteins transferred to a
PVDF membrane (Amersham Biosciences, Little Chalfont,
UK), and blocked using Superblock Blocking buffer
(Thermo Fisher Scientific, Massachusetts, USA) contain-
ing 0.1% of Tween-20 (Sigma-Aldrich) for 1 h at room
temperature. The primary antibodies: anti-PRF31 (1:3000,
Santa Cruz Biotechnology, SC-68347), mouse anti-
Rhodopsin, (1:1000, Abcam, ab190307), mouse anti-
RPE65, (1:5000, Abcam, ab78036), mouse anti-HSPA4L
(1:500, Santa Cruz Biotechnology, SC-137007), mouse
anti-HSP70 (1:2000, Santa Cruz Biotechnology, SC-24),
mouse anti-GAPDH (1:1000, Abcam, ab9484) and mouse
anti-γ-Tubulin (1:2000, Sigma-Aldrich, T-5192) were in-
cubated overnight at 4 °C. The primary antibody mouse
anti-FLAG® M2 (1:1500, Sigma, F3165) was incubated for
1 h at room temperature. The membrane was probed with
the appropriate anti-HRP-conjugated secondary anti-
bodies for 1 h at room temperature, and the immune-
reactive bands were detected by chemiluminescence using
ECL plus (Amersham Biosciences). Immunoreactive
bands were quantified by densitometric analysis using
ImageJ software, and normalized with GAPDH or γ-
tubulin immunoreactive bands.
Microarrays for gene expression analysis and alternative
splicing
Eight-month old WT and Prpf31A216P/+ mice were sacri-
ficed by cervical dislocation and total RNA from RPE
was extracted using High Pure RNA tissue kit (Roche,
Mannheim, Germany), according to manufacturer’s in-
structions. Quality of isolated RNA was evaluated by
RNA 6000 Nano assay on a 2100 Bioanalyzer (Agilent
Technologies, California, USA). The RNA extracted
from RPE/Choroid samples (100 ng) was used to pro-
duce end-labeled biotinylated ssDNA. The labeled
ssDNA was hybridized using oligonucleotide microarray
GeneChip® MTA 1.0 (Affymetrix, California, USA), ac-
cording to manufacturer’s instructions. The arrays were
scanned using the GeneChip® Scanner 3000 7G (Affyme-
trix) and analyzed with the GeneChip® Command Con-
sole Software (Affymetrix). The raw array data were pre-
processed and normalized using the Signal Space
Transformation-SST Robust Microarray Analysis-RMA
(Irizarry et al., 2003). Genes differentially expressed (fold
change linear < − 2 or > 2 and ANOVA p-value < 0.05)
were selected for further analysis. Gene ontology was
evaluated through the Database for Annotation,
Visualization and Integrated Discovery (DAVID) v6.8
(Sherman & Lempicki, 2009). For alternative splicing
analysis, the data was normalized by Robust Multiarray
Average-RMA and applying Detection Above the
Background-DABG method. The splicing index was de-
termined to evaluate the difference of expression of a
given exon between Prpf31A216P/+ and WT mice, exclud-
ing the influence of gene level expression. Exons differ-
entially expressed (splicing index = fold change linear <
− 2 or > 2 and ANOVA p-value < 0.05) were selected for
further analysis.
RT-PCR and quantitative RT-PCR (qPCR)
Total RNA from neuroretina and RPE samples was ex-
tracted using High Pure RNA tissue kit (Roche) accord-
ing to the manufacturer’s instructions. After
spectrophotometric quantification of RNA using Nano-
Drop1000 (Thermo Fisher Scientific), reverse transcrip-
tion was carried out using cDNAQuantiTect® reverse
transcription kit (Qiagen, Hilden, Germany), according
to manufacturer’s instructions. cDNA amplification was
performed by using 1 μg of RNA as template. Approxi-
mately 100 ng of cDNA was used for qPCR. Specific
primers for Prpf31 (Mm01329809_m1, Thermo Fisher
Scientific), Recoverin (Mm00501325_m1, Thermo Fisher
Scientific), Rpe65 (Mm00504133_m1, Thermo Fisher
Scientific) and Hspa4l (Mm00495441_m1, Thermo
Fisher Scientific) were used. The qPCR was performed
using TaqMan® Gene Expression Real Time qPCR assays
(Life-Technologies, California, USA) according to the
manufacturer’s instructions, using a Thermal Cycler
C100 (Bio-Rad). The average cycle threshold (CT) of
fluorescence units was used to analyze the mRNA levels.
Prpf31, Recoverin, Rpe65 and Hspa4l mRNA levels were
normalized by Gapdh RNA levels. Quantification was
calculated as: mRNA levels (percent of control) = 2Δ(CT)
with Δ (CT) = CT(Prpf31/Recoverin/Rpe65/Hspa4l)- CT(Gapdh).
Funduscopy
Mouse retinas were evaluated in vivo using an advanced
retinal-imaging microscope (MICRON III, Phoenix Re-
search Laboratories, Inc., California, USA). The animals
were anaesthetized by subcutaneous injection of keta-
mine hydrochloride/xylazine solution (80/12 mg/kg body
weight) and pupils were dilated with one drop of 10%
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phenylephrine and 1% tropicamide. Additionally, eyes
were locally anaesthetized with 0.1% tetracaine and 0.4%
oxybuprocaine and a generous amount of 1% methylcel-
lulose was placed on the mouse corneas to keep the eye
moist. Correct alignment of the eye and dilatation of the
pupils were checked before placing the camera lens in
contact with the cornea to visualize the retina. Finally,
images of the central and the peripheral regions of the
retina were repeatedly captured with a three-separate
charge-coupled device camera. A short wavelength exci-
tation filter (486.5 nm transmission band Tavg N 90%
451.5) and a long wavelength emission filter (transmis-
sion band Tavg N 93% 504.7–900 nm) were used to de-
tect autofluorescence signal.
ERG recordings
ERG is used to measure the electrical response of retinal
cells (photoreceptors, RPE cells, etc) to light stimuli.
Whole field ERG was recorded in a Ganzfeld Color
Dome (Diagnosys LCC). To assess scotopic vision, mice
were dark adapted overnight. Anesthesia and pupil dila-
tion of mice were performed as described above. A ring
electrode made of gold wire (active electrode) was placed
on the surface of the cornea which was previously
treated with a wetting agent (1% methyl cellulose). Nee-
dle electrodes made of stainless steel were used as refer-
ence (forehead) and ground electrodes (tail). The narrow
band filter was adjusted to frequencies of 0.312 to 300
Hz. A single flash white (6500 K) was used as stimulus
divided in 6 stages of progressive intensity at 0.01, 0.05,
0.2, 1, 3 and 10 cd (cd).s/m2. Fifteen responses were re-
corded at each stage with an interval of 15 s between
each stimulus. To evaluate photopic vision, mice were
adapted to light for 10 min with a background illumin-
ation of 30 cd/m2. The intensity of the stimulus was 3, 5,
10, 15 and 20 cd.s/m2. The amplitude and frequency of
a- and b-waves were evaluated. To measure the c-wave
the narrow and broad band filters were adjusted to 0.1
Hz and 30 Hz, respectively. The c-wave value was mea-
sured at the maximum peak of the c-wave. A single
green flash of 64 cd/m2 during 200ms was used was
used as stimulius and the recording was extended until
4 s.
Plasmids
pEGFP-N1 (Clontech, Michigan, USA) containing the
CMV promoter was used as backbone. Human PRPF31
was amplified with specific primers containing NheI (5′)
and BamHI (3′) restriction sites. PRPF31A216P was ob-
tained by using a GeneArt® Site-Directed Mutagenesis
System kit (Invitrogen, California, USA). The amplified
fragments were cloned in pEGFP-N1. The resulting con-
structs (PRPF31-GFP and A216P-GFP) were confirmed
by restriction enzyme digestion and sequencing. The
pcDNA3.1-PRPF31-C(K) DYK plasmid (PRPF31-Flag)
was acquired from GenScript (New Jersey, USA).
Cell culture
Human RPE cell line ARPE-19 (ATCC® CRL-2302™) was
kept in culture at 37 °C in a humid chamber with 5%
CO2 and grown in Dulbecco’s modified Eagle’s medium
F12 (DMEM/F12; Sigma-Aldrich) supplemented with 1%
penicillin/streptomycin (Sigma-Aldrich), 1% glutamine
(Sigma-Aldrich), and 10% fetal bovine serum (Sigma-Al-
drich). Culture medium was changed every 2 days.
Transfection was performed using Lipofectamine 2000
(Invitrogen) with a 3:1 (μL of Lipofectamine 2000/μg of
DNA) ratio, according to manufacturer’s instructions.
Briefly, 7.5 × 105 cells were seeded in a 6-cm culture dish
(Orange Scientific, Belgium), and 24 h after seeding, cells
were transfected with 1 μg of DNA. Twenty-four-hour
post-transfection, cells were either fixed or collected for
protein isolation, depending on the experiment. Cells
were also transfected with the PRPF31-GFP or A216P-
GFP plasmids alone and co-transfected with the
PRPF31-Flag plasmid.
Fluorescence recovery after bleaching (FRAP) assay
ARPE-19 cells transfected either with PRPF31-GFP or
A216P-GFP constructs were used for FRAP experiments.
FRAP assay was performed using a laser scanning con-
focal microscope TCS SP5 (Leica) equipped with an en-
vironmental control system for temperature (37 °C),
humidity and CO2 concentration (5%). Briefly, trans-
fected cells from each condition were selected and im-
aged before bleaching. Photo-bleaching was applied in a
circular region of interest-ROI of the same diameter po-
sitioned in the cell nucleus of the selected cells using an
Argon laser (488 nm). Pre-bleached images were re-
corded for 3 s (1 s/frame) and the selected area was
bleached for 1 s with a pulse of 488-nm laser, at max-
imum intensity. After bleaching, a series of images were
captured every second for 200 s. Normalization was per-
formed using the values before bleaching and the first
time point after bleaching.
Statistical analysis
The SSPS software was used for statistical analysis. All ex-
perimental measurements were expressed as the means ±
SEM or quartiles in boxplot diagrams. Normal distribution
of samples was evaluated by Kolmogorov-Smirnov. The
samples of both eyes were pooled in one sample for protein
and mRNA extractions. Statistically significant differences
between groups were estimated by t-test, one-way ANOVA
or the nonparametric Mann-Whitney U-test. A p value <
0.05 was considered statistically significant.
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Results
Prpf31A216P/+ KI mice display RPE degeneration with
drusen-like deposits
To better understand the role of Prpf31 in retinal degen-
eration, we have used heterozygous Prpf31A216P/+ KI
mice (Bujakowska et al., 2009), a mouse model which
carries the point-mutation p.A216P in the Prpf31 gene,
known to be responsible for adRP in humans (Vithana
et al., 2001). However, in mice p.A216P does not pro-
duce a photoreceptor cell death phenotype as it does in
humans. On the other hand, it is known that Prpf31+/−
KO mice display an RPE-degenerative phenotype. For
this reason, we decided to characterize, in detail, the
RPE-degenerative phenotype of aged KI mice. We
started by studying funduscopy images in 8 to 16-
month-old mutant mice and their WT-littermates to
evaluate the appearance of the retina. Ophthalmoscopic
images of the central and peripheral regions of the retina
showed normal appearance in the WT mice (Fig. 1a-d).
The homogeneity in the surface of the central (Fig. 1a)
and peripheral (Fig. 1b) retina is clearly shown, as well
as the normal size of the optic nerve head (Fig. 1c) and
the normal thickness of the blood vessels (Fig. 1d; white
arrowhead). In contrast, small round, white-yellowish,
non-confluent, scattered lesions were observed through-
out the retina of Prpf31A216P/+ mice like drusenoid de-
posits (Fig. 1e-h). Most of these lesions were
autofluorescent (Fig. 1i-j; white arrows). The number of
drusen-like deposits begins to be observed since the 8th
month, and their number progressively increases in a
non-homogeneous way during the retinal degenerative
process. In the mutant mice evaluated we did not ob-
serve any of the typical fundus features of RP, such as
black pigment accumulation in the form of bone spic-
ules, vascular sharpening or optic nerve head atrophy.
TEM of 8-month-old WT (Fig. 1k, l) and KI retinas
(Fig. 1m-o) was also performed to evaluate the morph-
ology of RPE cells and the Bruch’s membrane in detail.
In the WT mice, the normal expected morphology for
RPE was observed, with the presence of photoreceptor
outer segments (OS) in contact with RPE apical micro-
villi (Mv) (Fig. 1k; OS and Additional file 1: Figure S1a),
melanin and lipofuscin granules in the cytoplasm (Fig. 1k;
Me, Lf) as well as basal infoldings of the RPE membrane
(Fig. 1 k; BI) in contact with the Bruch’s membrane
(Fig. 1 k; BM). Bruch’s membrane presented a well-
defined fundamental structure (Fig. 1l; fs) between each
basal lamina, one corresponding to the RPE and the other
to the endothelium of a choroidal vessel (Fig. 1l; BL, ar-
rowheads). The thickness of the Bruch’s membrane mea-
sured between both basal laminae was 400 nm (Fig. 1 l). In
contrast, Prpf31A216P/+ TEM images showed, accumula-
tion of lipofuscin granules (Fig. 1m, o; Lf), vacuolization of
the RPE (Fig. 1m; Va), atrophy of basal infoldings (Fig. 1m;
BI) and thickening of Bruch’s membrane (Fig. 1 m; BM),
to an approximate size of 700 nm (Fig. 1n). Additionally,
the homogeneity of the fundamental membrane structure
was lost (Fig. 1n; fs) and we also found accumulation of
amorphous electrodense material within the Bruch’s
membrane (Fig. 1o; black arrow). The Mv and the end of
OS in mutant mice were also observed. Mv were shorter
and disorganized when compared with the Mv of WT
mice (Additional file 1: Figure S1). Despite all these alter-
ations, the Prpf31A216P/+ mice did not show any damage of
the photoreceptor.
In addition, specific staining methods were used to
visualize lipofuscin granules (Fig. 1p, r). Large accumula-
tion of lipofuscin granules was observed in the RPE of
the mutant mice (Fig. 1r; dark magenta) compared to
WT (Fig. 1p). To evaluate the composition and
localization of the amorphous material observed in the
Bruch’s membrane, Filipin blue staining was used to de-
tect free cholesterol (Fig. 1q, s, t; blue). Immunofluores-
cence for laminin (Fig. 1 q, s, t; red) and Rpe65 (Fig. 1q,
s, t; green) are shown as markers of basal lamina and
RPE, respectively. In the KI mice, accumulation of free
cholesterol was observed between the RPE and the
Bruch’s membrane (Fig. 1s) or between both basal lam-
inae (Fig. 1t). Localization of these deposits is similar to
the basal linear deposits and basal lamellar deposits de-
scribed by Curcio and colleague in age-related macular
degeneration (AMD) (Curcio & Millican, 1999). RPE at-
rophy, lipofuscin accumulation and thickening of
Bruch’s membrane are also features described in AMD
(Curcio & Millican, 1999; Ding et al., 2009).
Finally, we have monitored ERG responses in the KI
mice and found that a- and b-waves, corresponding to
photoreceptor electrical activity, were not affected (Add-
itional file 1: Figure S2a-c”). This is similar to what was
previously reported for all splicing factor-mutant mouse
models (Bujakowska et al., 2009; Farkas et al., 2014).
Surprisingly, a defective c-wave was observed, reflecting,
at a functional level, the specific degenerative changes
found in the RPE layer (Additional file 1: Figure S2d-d”).
Therefore, the Prpf31A216P/+ mice display RPE degener-
ation with drusen-like deposits.
PRPF31 is highly expressed in the RPE
We have analysed expression of Prpf31 in retinal sam-
ples of WT CD-1 mice to examine its distribution in the
different retinal layers. Immunohistochemistry (Fig. 2)
shows Prpf31 to be highly expressed in the RPE cell
layer (Fig. 2a; arrowheads) compared to neuroretina,
where almost no Prpf31 signal was detected. Rhodopsin,
the photo-pigment expressed in rod-photoreceptors, was
used as a positive control for the immunohistochemical
staining (Fig. 2b) and, as expected, a clear signal was dis-
played in the photoreceptor OS. A negative control,
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without primary antibody, was performed to discard
non-specific binding of secondary antibody (Fig. 2c).
To compare differential expression of Prpf31 protein in
different layers of the mouse retina, neuroretina and RPE
were manually dissected and protein and mRNA samples
were obtained from each fraction. Immunoblotting results
indicate high expression of Prpf31 protein compared to
the neuroretina (Fig. 2d). Antibodies against Rhodopsin
and Rpe65, an enzyme of the visual cycle cascade
expressed in the RPE, were used as fraction-specific
markers (Fig. 2d). This result was further confirmed by
qPCR (Fig. 2e), in which it is possible to observe that
Prpf31 expression level is much higher in the RPE, when
compared to its expression in the neuroretina. Recoverin
Fig. 1 Prpf31A216P/+ mice exhibit degenerative phenotype of the RPE with drusen-like deposits. Funduscopy of WT (a-d) and Prpf31A216P/+ mice (e-
j) are shown. Numerous white-yellowish round lesions were observed in the retina of Prpf31A216P/+ mice (e-h). These lesions were distributed in
the central (g) and peripheral retina (h) and most of them showed autofluorescence (i, j; white arrows). The optic nerve head (g) and retinal
vessels (h; white arrowhead) did not show differences when compared to WT mice (c, d; white arrowhead). TEM images of RPE of 8-month-old
WT (k, l) and Prpf31A216P/+ mice (m-o) and the amplified images of Bruch’s membrane (BM) are displayed (l, n, o). Photoreceptor outer segments
(OS) were observed in contact with the RPE microvilli in WT mice (k). Accumulation of lipofuscin granules (Lf), large vacuoles (Va) and atrophy of
basal infoldings (BI) were observed in the RPE of Prpf31A216P/+ mice (m). The distance between both basal laminae (BL) was measured (l, n;
arrowheads), and thickening of the BM was detected in Prpf31A216P/+ mice (n). In addition, the homogeneity of the fundamental substance (fs)
was lost and amorphous electrodense material was accumulated within the BM of these mice (o; black arrow). The morphology of melanin
granules (Me), nuclei (Nu) and choroid (Co) was normal. Lipofuscin staining in dark magenta (p, r) showed large accumulation of lipofuscin
granules in the RPE of Prpf31A216P/+ mice (r). Filipin blue dye was used to stain free cholesterol (q, s, t; blue). Prpf31A216P/+ mice showed free
cholesterol accumulation (s, t; blue) between the RPE and BM (s) or within the BM (t). Anti-Laminin antibodies were used to stain the BL (q, s, t;
red) and the RPE was visualized by anti-Rpe65 antibody (q,s, t; green). Scale bars represent 2 μm (k-o) or 12.5 μm (p-t)
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and Rpe65 mRNAs were used as markers for neuroretina
and RPE fractions, respectively (Fig. 2f-g).
To confirm whether this differential distribution of
PRPF31 along the retinal cell types is common to other
vertebrates, fractions of RPE and neuroretina were ob-
tained from C57BL/6 J mice, pig, cow and human eye
samples. The immunoblot for PRPF31 (Additional file 1:
Figure S3) showed that protein level is comparatively
higher in the RPE than in the rest of the retinal layers in
several vertebrates, including humans.
Mutant PRPF31 protein is aggregated in the cytoplasm of
RPE cells
Next, we were interested in the distribution of the
Prpf31 protein histologically in the RPE of the aged-KI
mice. Immunofluorescence analysis of Prpf31 protein
did not show clear differences between WT and KI mice
in retinal sagittal sections. However, RPE whole-mount
evaluation showed large cytoplasmic aggregates of
Prpf31 protein in Prpf31A216P/+, which were almost not
present in the WT samples (Fig. 3e-h). Additionally, a dif-
ference in the Prpf31 distribution within the RPE cell was
observed, with a weaker staining in the KI nuclei com-
pared to the WT-littermates (Fig. 3e-h). In the WT RPE
cells, most of Prpf31 is localized inside the nucleus with
some homogeneous cytoplasmic staining (Fig. 3a-d) but in
the Prpf31A216P/+ RPE cells, most of the Prpf31 staining is
shown in the cytoplasm forming rounded clumps of
Prpf31 protein resembling aggregates (Fig. 3e-h). Cells
that were observed harbouring protein aggregates formed
clusters in the RPE layer of the KI mice. The number of
cells with cytoplasmic aggregates was counted in both KI
and WT mice, providing a statistically significant differ-
ence, with Prpf31A216P/+ mice having 18.4 ± 2.3% of RPE
cells with cytosolic aggregates compared to 1.7 ± 0.2% cells
in the WT mice (Fig. 3i).
To quantify the amount of Prpf31 signal in the RPE
nuclei, the Manders’ overlap coefficient for
DAPI+Prpf31/DAPI colocalization (M1) and for
Prpf31 + DAPI/Prpf31 colocalization (M2) were calcu-
lated (Fig. 3j). Both coefficients were significantly lower
in the mutant mice (Fig. 3j), corresponding to the dimin-
ished amount of Prpf31 protein in the nucleus of RPE
cells as observed by histology. Besides, Western blot of
cytosolic and nuclear fractions clearly showed a decrease
of Prpf31 protein in the nuclear fractions of mutant mice
(Fig. 3k). Therefore, these results show that not only
Prpf31 protein in the Prpf31A216P/+ mice is aggregated in
the cytoplasm of the RPE cells, but also its concentration
in the nuclei is decreased when compared to the WT.
Fig. 2 Prpf31 protein and its mRNA are highly expressed in the RPE of mouse retinas. Immunohistochemical staining showed strong Prpf31 signal
in the RPE of CD-1 mouse retinas (a; arrowheads). Anti-Rhodopsin antibodies were used as positive control for immunohistochemical staining (b).
A negative control without primary antibodies is also present (c). Western blot (d) and qPCR (e) analysis of Prpf31 protein and mRNA expression
in the neuroretina and RPE samples showed that it is mainly expressed in the RPE (d, e). Anti-Rhodopsin and anti-Rpe65 antibodies were used as
controls for the neuroretina/RPE tissue fractions, and anti-Gapdh antibody was used as a loading control (d). For qPCR, Recoverin (f) and Rpe65 (g)
mRNA expression levels were used as controls for the two different tissue fractions. The bars in the graphs e-g represent means of fold change ±
SEM (n = 4 replicates of 3 samples in each group). Statistically significant differences were determined by t-test (*p < 0.05, **p < 0.01). RPE =
retinal pigment epithelium, OS = outer segment, IS = inner segment, ONL = outer nuclear layer, INL = inner nuclear layer, GCL = ganglion cell layer.
Scale bars represent 50 μm
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Fig. 3 Large cytoplasmic aggregates of Prpf31 protein were observed in the RPE of Prpf31A216P/+ mice. Whole-mount of the RPE layer from WT (a-
d) and Prpf31A216P/+ mice (e-h) were immunostained with anti-Prpf31 antibodies (a, e). Cell nuclei were stained with DAPI (b, f), and TRITC-
phalloidin was used to visualize the F-actin microfilaments (c, g). Prpf31 signal was mainly localized in the nuclei of WT RPE cells (a), while large
protein aggregates stained for PRPF31 were observed in the cytoplasm of RPE cells of mutant Prpf31A216P/+ mice (e). The bars in graph i represent
the percentage of RPE cells with cytoplasmic aggregates of Prpf31 protein ± SEM in WT and Prpf31A216P/+ whole mount RPE samples (n = 1200
cells were counted from 4 mice in each group). The boxplot j represents the Manders’ overlap coefficient of DAPI+Prpf31/DAPI colocalization
(M1) and Prpf31 + DAPI/Prpf31 colocalization (M2) in WT and Prpf31A216P/+ whole-mount RPE samples (n = 4 in each group). Expression of Prpf31
protein was evaluated in the cytosolic and nuclear fractions by Western blot (k). Statistically significant differences were determined by t-test or
Mann-Whitney U-test (*p < 0.01, **p < 0.001). Scale bars represent 25 μm
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The antibody used to visualize Prpf31 recognized both
mutant and normal Prpf31 protein, thus we were unable
to determine whether the aggregates are composed
solely of the mutated protein or if the WT protein is also
present in the aggregates.
Differential gene expression and alternative splicing were
affected in Prpf31A216P/+ mice
Considering that the mutant Prpf31 protein is aggregated
in the cytoplasm of RPE cells in Prpf31A216P/+ mice, we
decided to perform transcriptomic analysis using a Gene-
Chip™ Mouse Transcriptome Array (MTA) 1.0 to evaluate
differential gene expression in RPE samples of six
Prpf31A216P/+ and three WT-littermates. The number of
genes evaluated was 65,956 and, from these, a total of
1033 (1.6%) genes were differentially expressed in the
Prpf31A216P/+ mice. Most of these genes were upregulated
(922, 89.3%) and the rest were downregulated (Table 1;
Additional file 2, Gene expression). The gene-level differ-
ential expression analysis is graphically displayed in the
volcano plot (Fig. 4a). Each point on the plot represents
the statistical result of a single gene. Horizontal axis repre-
sents fold change in log2 scale and vertical axis represents
p-value in log10 scale. Threshold of fold change was either
< − 2 (Fig. 4a; blue) or > 2 (Fig. 4 a; red) and ANOVA p-
value < 0.05. Gray dots correspond to the genes without
statistically significant change. Hierarchical clustering of
1033 genes differentially expressed in Prpf31A216P/+ vs WT
mice is shown in Fig. 4b with an expression profile clearly
different for WT and Prpf31A216P/+ clusters (Fig. 4b).
Gene ontology was evaluated through the informatic
tool DAVID v6.8 (Sherman & Lempicki, 2009) using the
list of 1033 genes which were differentially expressed in
Prpf31A216P/+ mice, showing that the largest group of
genes (123 genes) affected by the mutation belongs to Pro-
tein Binding (Additional file 1: Table S1). This molecular
function is defined as: interacting selectively and non-
covalently with any protein or protein complex (GO:
0005515), including the subcategory chaperone binding
(GO:0051087); a class of proteins that bind to nascent or
unfolded polypeptides to ensure correct folding or trans-
port. Because the most relevant change observed in the
RPE of the mutant mice was the cytoplasmic aggregation
of Prpf31 protein, we decided to look for candidate genes
related to molecular chaperones involved in protein fold-
ing. We found that heat shock protein family A (Hsp70)
member 4 like gene (Hspa4l), which encodes the
chaperone heat shock 70 kDa protein 4 L (Hspa4l), was
upregulated in Prpf31A216P/+ mice (fold change 2.26; p-
value 0.009). Other chaperones involved in the unfolded
protein response were not highlighted with a different
gene expression level. Lists of candidate genes found to be
differentially expressed which might also be involved in
RPE degeneration are shown in Additional file 1: Table
S2.
Alternative splicing analysis was also performed
through the GeneChip™ MTA 1.0 in the same RPE sam-
ples of six Prpf31A216P/+ and three WT-littermates. A
total of 65,770 genes were evaluated and 92.6% (60871)
of these genes were expressed in both mice
(Prpf31A216P/+ and WT mice). From these 60,871 genes,
6700 (11%) genes have, at least, one differentially
expressed probe selection region or junction to indicate
alternative splicing (Table 2; Additional file 3, Splicing).
The scatter plot (Fig. 4c) displays the number of genes
that are alternatively spliced in Prpf31A216P/+ mice with
lower < − 2 (Fig. 4c; red) or higher > 2 (Fig. 4 c; blue)
splicing index, when compared to WT mice.
Functional categories of alternative spliced genes in
the RPE of Prpf31A216P/+ mice are listed in the Add-
itional file 1: Table S3. We observed that several splicing
factors, including Prpf31, present a different splicing
index (Prpf31 splicing index − 2.33, p-value 0.04; Prpf18
splicing index − 2.62, p-value 0.01; Prpf39 splicing index
2.25, p-value 0.03). Apart from the aforementioned spli-
cing factors, others genes of different pathways involved
in retinal degeneration were also affected by the muta-
tion, such as inflammation, oxidative stress, retinol me-
tabolism (Abca4), ciliogenesis (Bbs1, Bbs4, Bbs5, Bbs7,
Bbs9) and cellular apoptosis (Additional file 1: Table S4;
Table 1 Summary of gene level differential expression analysis in RPE samples in two different conditions (Prpf31A216P/+ vs WT mice).





Number of genes differentially
expressed (%)
Number of genes up-
regulated (%)
Number of genes down-
regulated (%)
Non-coding 36,703 (55.7) 562 (0.9) 485 (47.0) 77 (7.5)
Complex 15,644 (23.7) 280 (0.4) 264 (25.6) 16 (1.5)
Coding 10,692 (16.2) 151 (0.2) 134 (12.9) 17 (1.6)
Pseudogene 2711 (4.1) 40 (0.1) 39 (3.8) 1 (0.1)
Ribosomal 155 (0.2) 0 (0.0) 0 (0.0) 0 (0.0)
Unassigned 51(0.1) 0 (0.0) 0 (0.0) 0 (0.0)
Total 65,956 (100.0) 1033 (1.6) 922 (89.3) 111 (10.7)
MTA 1.0, genome version mm10
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Fig. 4 Differences in the level of gene expression and alternative splicing in the RPE of Prpf31A216P/+ mice compared to WT controls. Volcano plot
(a) showing the genes that are upregulated (red) or downregulated (blue) in Prpf31A216P/+ KI mice with a significance ANOVA p value < 0.05 and
fold change < −2 or > 2 when compared with WT mice. Hierarchically clustered (b) genes (rows) and WT or KI mice (columns) with dendrograms
and flat clusters; red in the heatmap denotes upregulation while blue denotes downregulation. Scatter plot (c) presents the genes that are
alternatively spliced in Prpf31A216P/+ mice with lower (red) or higher (blue) splicing index when compared with WT mice (WT n = 3 and
Prpf31A216P/+ n = 6)
Table 2 Summary of alternative splicing analysis in RPE samples in two different conditions (Prpf31A216P/+ vs WT mice). Default filter





Number of genes expressed in both
conditions (%)
Genes with at least one differentially expressed PSR or junction to
indicate alternative splining (%)
Non-coding 36,581 (55.6) 33,587 (51.1) 929 (1.5)
Complex 15,644 (23.8) 15,056 (22.9) 4344 (7.1)
Coding 10,628 (16.2) 9450 (14.4) 1381 (2.3)
Pseudogene 2711 (4.1) 2601 (3.9) 29 (0.1)
Ribosomal 155 (0.2) 155 (0.3) 16 (0.0)
Unassigned 51(0.1) 22 (0.0) 1 (0.0)
Total 65,770 (100.0) 60,871 (92.6) 6700 (11.0)
MTA 1.0, genome version mm10. PSR probe selection region
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Additional file 3, Splicing). The number of candidate
genes with modified splicing index that can be involved
in RPE degeneration are detailed in Additional file 1:
Table S4. These results suggest that normal splicing of
different genes, including splicing factors, is affected in
the RPE of Prpf31A216P/+ mice.
Increased Hspa4l expression and colocalization with
mutant Prpf31 protein in the RPE of Prpf31A216P/+ mice
Analysis of transcriptomic data show that a member of
the heat shock protein 70 (HSP70) family, Hspa4l, was
overexpressed in the RPE of KI mice. The HSP70 family is
a ubiquitous and conserved family of molecular chaperons
assisting in protein folding to prevent aggregation and to
protect cells from stress (Mashaghi et al., 2016; Mayer &
Bukau, 2005). We have analyzed mRNA expression of
Hspa4l by qPCR in both RPE and neuroretina of the KI
mice and we found that Hspa4l is overexpressed in the
RPE of the mutant mice, when compared to its expression
in the WT mice (Fig. 5a). No differences of Hspa4l expres-
sion in the neuroretina extracts were observed (Fig. 5a).
This result was corroborated by Western blot in which we
observed that Hspa4l was more abundant in the RPE of
the mutant mice (Fig. 5b). RPE whole-mount immuno-
fluorescence to localize Hspa4l and Prpf31 was also per-
formed. As previously mentioned, Prpf31 protein
predominantly localizes in RPE nuclei of WT samples
(Fig. 5c, f; arrowhead) and in cytoplasmic aggregates in
the case of KI tissue and low expression in the nucleus
(Fig. 5i, l; arrow). As expected, Hspa4l staining is stronger
in the mutant RPE cells, where the chaperone colocalizes
with Prpf31 protein aggregates (Fig. 5i-n). The hexagonal
shape of the RPE can be seen with phalloidin staining
(Fig. 5c-n; blue). Negative controls for RPE autofluores-
cence and secondary antibodies nonspecific bindings are
shown in the Additional file 1: Figure S4. The small heat
shock protein, Hsp27, also colocalized with the Prpf31 ag-
gregates in the RPE of mutant mice (Additional file 1: Fig-
ure S4), but transcriptomic data did not show differential
expression of its gene (Hspb1).
The p.A216P mutant protein produces insoluble
cytoplasmic aggregates, recruits endogenous PRPF31
protein in the insoluble fraction and increases the
expression of HSP70
To better understand the role of p.A216P mutation in
human-derived RPE cells, we have cloned the human
WT PRPF31 and the A216P mutant genes in pEGFP-N1
plasmid and the GFP-tagged PRPF31 proteins were over-
expressed in ARPE-19 cells. We observed that WT
PRPF31-GFP was mainly found in the nucleus of the
transfected cells (Fig. 6a-c and g-i), while the mutant
A216P-GFP was mostly aggregated in the cytoplasm of
the transfected cells (Fig. 6d-f and j-l), similar to our
previous observation in the RPE of the WT and
Prpf31A216P/+ mice, as shown in Fig. 3.
Western blot analysis of detergent-soluble and detergent-
insoluble fractions of the cell lysates was conducted to esti-
mate the concentration of PRPF31 in both fractions.
Western blotting and densitometry analysis of the immu-
noblots (Fig. 6m, n) show less mutant protein A216P-GFP
in the soluble fraction compared to PRPF31-GFP protein,
and the opposite in the detergent-insoluble fraction
(Fig. 6m, n). Additionally, it is possible to observe a deple-
tion of the endogenous PRPF31 protein in the soluble frac-
tion and highest levels of expression in the insoluble
fraction (Fig. 6m), suggesting that the cytoplasmic insoluble
aggregates of A216P-GFP protein recruit the endogenous
WT PRPF31 protein. To evaluate whether the WT PRPF31
protein increased in the insoluble fraction in cells co-
transfected with the mutant protein PRPF31 (A216P),
ARPE-19 cells were co-transfected with WT PRPF31
tagged to Flag (PRPF31-Flag) and PRPF31-GFP or A216P-
GFP. After 24 h of incubation, the protein extracts of sol-
uble and insoluble fractions were analyzed by Western blot-
ting (Fig. 6o). It was observed that the WT protein tagged
to GFP was expressed in both the soluble and insoluble
fraction, while the mutant protein was expressed mostly in
the insoluble fraction (Fig. 6o). Besides, it was found that
the WT protein tagged to Flag decreased in the soluble
fraction and increased in the insoluble fraction only in
those cells expressing the PRPF31 protein carrying the
p.A216P mutation. In this way, we confirm our hypothesis
that the mutant PRPF31 protein recruits the WT protein in
the insoluble fraction.
HSP70 plays an important role in retinal dystrophies,
including RP (Furukawa & Koriyama, 2016) so we have
also evaluated the distribution and expression of HSP70
protein in the ARPE-19 cells overexpressing either
PRPF31-GFP or A216P-GFP by immunofluorescence
and Western blotting. In the immunofluorescence stain-
ing, PRPF31-GFP transfected cells show a weak labeling
of HSP70 in the nucleus (Fig. 7a-d). However, in A216P-
GFP transfected cells, HSP70 staining is increased, and
its signal colocalizes with the cytoplasmic aggregates of
mutant PRPF31 protein (Fig. 7e-h), similar to the distri-
bution observed for Hspa4l in the RPE of Prpf31A216P/+
mice. Additionally, Western blot analysis of the soluble
and insoluble fractions (Fig. 7i) and its densitometry
analysis (Fig. 7j) show an increase of HSP70 in the insol-
uble fraction of the cells transfected with A216P-GFP.
Therefore, protein aggregation of mutant PRPF31 seems
to activate the response of chaperones.
P.A216P mutation affects the mobility of PRPF31 protein
to the nucleus in human RPE derived live cells
FRAP experiments provide qualitative and quantitative
information about the mobility of a fluorescently tagged
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Fig. 5 (See legend on next page.)
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protein in a defined compartment (Phair & Misteli,
2001; Reits & Neefjes, 2001). Different parameters can
be evaluated by FRAP, such as the mobile fraction (mf)
of a fluorescent-tagged protein and its half-life (τ1/2).
The mf can be affected by different circumstances, such
as interaction of the fluorescent-tagged protein with
other proteins, cytoplasmic organelles or membranes.
Considering that p.A216P mutation induces protein ag-
gregation and expression of HSP70, which colocalizes
with the cytoplasmic aggregates of PRPF31 protein, we
decided to investigate whether the translocation of
PRPF31 protein from the cytoplasm to the nucleus was
affected in living cells. To test this hypothesis, we have
performed FRAP assay in ARPE-19 cells (Fig. 8). The
cell line was transfected with the plasmids pEGFP-N1,
PRPF31-GFP and A216P-GFP and FRAP was performed
as described in the Methods section of this manuscript.
Pre- and post-photobleached cells are displayed in
Fig. 8a-l, showing that the amount of PRPF31 protein re-
covered in the nucleus 200 s after bleaching is affected
by the mutation (Fig. 8l) but not in pEGFP-N1 (Fig. 8d)
or PRPF31-GFP (Fig. 8h) transfected cells. A slower re-
covery curve for A216P-GFP were clearly observed when
compared to the control PRPF31-GFP (Fig. 8m).
The changes produced in the recovery curve were
due to changes in the size of mf and not due to
changes in the τ1/2, which is defined as the time
when the recovery of fluorescence intensity is half of
the plateau (τ1/2 PRPF31-GFP = 7.40 ± 3.08 s; τ1/2
A216P-GFP = 7.00 ± 2.66 s; p = 0.46). However, the mf
significantly decreased in A216P-GFP transfected cells
(mf PRPF31-GFP = 0.55 ± 0.10; mf A216P-GFP =
0.27 ± 0.15; p < 0.05) (Fig. 8n). The mf was deter-
mined by comparing the fluorescence in the bleached
region after full recovery (F∞) with the fluorescence
before bleaching (Fi) and just after bleaching (F0), be-
ing defined as mf = (F∞ – F0)/(Fi – F0). The fluores-
cence intensity was normalized to the Fi and F0 in
the Fig. 8m. The A216P-GFP transfected cells showed
less F∞ than the control (Fig. 8m). These results sug-
gest that p.A216P mutation decreases the amount of
PRPF31 protein that moves to the nucleus but with-
out affecting the diffusion time.
Discussion
PRPF31 is a ubiquitously expressed gene encoding for a
component of the spliceosome complex involved in pre-
mRNA processing. Mutations in this gene are associated
with non-syndromic adRP, but the mechanism by which
retinal degeneration occurs, is still unknown. Previously,
two mutant mouse models (Prprf31+/− and Prpf31A216P/+)
were generated to study the role of PRPF31 in the patho-
genesis of adRP, but neither of these models presented ev-
idences of RP-like photoreceptor degeneration, leading to
conclude that the presence of one copy of WT-Prpf31 al-
lele is sufficient to maintain the normal retina, and that
the p.A216P mutation does not exert a dominant-negative
effect (Bujakowska et al., 2009).
It has previously been described that the Prprf31+/− KO
mice (Farkas et al., 2014; Graziotto et al., 2011), as well as
other splicing-factor mouse models that do not present
photoreceptor-degenerative phenotype, have an RPE-
degenerative phenotype. In this study, a deep phenotypic
characterization of 8 to 16month-old Prpf31A216P/+ mice
was performed to understand how the p.A216P mutation
affects RPE function and we found evidence that supports
a combination of haploinsufficiency and dominant-
negative effect. Fundus analysis showed a severe RPE de-
generation, with the presence of white-yellowish and auto-
fluorescent spots in mutant mice. Concomitant functional
impairment was detected in ERG c-wave. TEM images ac-
cordingly showed some typical features of degenerative
RPE such as vacuolization, atrophy of basal infoldings,
thickening of Bruch’s membrane and accumulation of
amorphous electrodense material within this membrane.
Two previous studies (Farkas et al., 2014; Graziotto et al.,
2011) reported that two-year-old Prpf3T494M/+ and
Prpf8H2309P/+ and the one-year-old Prpf31+/− mice had
similar features to the ones that we have found in 8-
month-old Prpf31A216P/+ mice. The earlier onset of RPE
degeneration in Prpf31A216P/+ might indicate a possible
toxic effect of the p.A216P mutant protein.
In addition to the RPE atrophy, we have also observed
accumulation of lipofuscin granules and drusen-like de-
posits of free cholesterol between the RPE and the
Bruch’s membrane or between both basal laminae.
These deposits are similar to the basal linear deposits
(See figure on previous page.)
Fig. 5 Hspa4l is highly expressed in the RPE of Prpf31A216P/+ mice. Analysis of Hspa4l expression by qPCR in the neuroretina and RPE samples
show that Hspa4l mRNA is overexpressed in the RPE of Prpf31A216P/+ mice (a). The boxplot a represents the fold change of Hspa4l expression in
the neuroretina and RPE of WT and Prpf31A216P/+ mice (WT n = 3 and Prpf31A216P/+ n = 6). Statistically significant differences were determined by
Mann-Whitney U-test (*p < 0.05). Western blot of RPE samples showed higher expression of Hspa4l protein in Prpf31A216P/+ mice compared to WT
(b). Anti-Gapdh antibodies were used as loading control (b). Whole-mount of the RPE obtained from WT (c-h) and Prpf31A216P/+ mice (i-n) were
immunostained with anti-Prpf31 (c, f, i, l) and anti-Hspa4l antibodies (d, g, j, m). TRITC-phalloidin was used to stain F-actin microfilaments (c-n;
blue). Magnified images are (f-h and l-n) and merged are shown (e, h, k, n) Prpf31 signal was mainly distributed in the nuclei of RPE cells in WT
mice (c, f; arrowhead), while Prpf31 protein aggregates were observed in the cytoplasm (i, l) colocalizing with Hspa4l signal in mutant
Prpf31A216P/+ mice as shown in the merged images (k, n). Prpf31 signal was very low in the nuclei of Prpf31A216P/+ mice (l; arrow). Scale bars
represent 25 μm
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and basal lamellar deposits described in AMD patients
(Curcio & Millican, 1999). RPE atrophy, lipofuscin accu-
mulation and thickening of Bruch’s membrane are char-
acteristic histological hallmarks found in human AMD
patients, and these features have been also described in
animal models of RPE degeneration (Curcio & Millican,
1999; Pennesi et al., 2012). Therefore, the Prpf31A216P/+
mice display a primary RPE degeneration phenotype
with drusen-like deposits. Although RP phenotype is
predominantly associated with PRPF31 mutations in
humans, some affected individuals developed juvenile
macular degeneration apart from the typical RP pheno-
type, as described in two Chinese families carrying dif-
ferent mutations in the PRPF31 gene (Lu et al., 2013; Xi
et al., 2005). These results suggest that mutations in the
PRPF31 gene could produce not only a characteristic RP
Fig. 6 Overexpression of A216P-GFP induces aggregation of PRPF31 protein. The ARPE-19 cell line was transfected with PRPF31-GFP (a-c, g-i) and
A216P-GFP (d-f, j-l). The GFP-tagged proteins (green) and immunostained cells with anti-PRPF31 antibodies (red) are shown. PRPF31-GFP was
found mainly in the cell nucleus (a-c; 1, g-i) and to a lesser extent, in the cytoplasm (a-c; 2). A216P-GFP transfected cells present PRPF31
aggregation in the cytoplasm (d-f; 3, j-l), and a very minor signal in the nucleus (d-f; 4). Images correspond to a maximum projection of a Z-
stack. Western blot analysis of soluble and insoluble fractions of the transfected cells show a decrease in the concentration of endogenous
PRPF31 in the detergent-soluble fraction and an increase in the detergent-insoluble fraction of the cells transfected with A216P-GFP. Anti-γ-
tubulin antibody was used as loading control (m). Densitometry quantification of the blots (n) shows a significant increment of A216P-GFP
protein in the detergent-insoluble fraction when compare with the among of A216P-GFP protein present in the soluble fraction (n). The boxplot
n represents the ratio PRPF31/γ-tubulin in the soluble and insoluble fractions of PRPF31-GFP and A216P-GFP transfected ARPE-19 cells (n = 3 in
each group). Statistically significant differences were determined by Mann-Whitney U-test (*p < 0.05). Western blot analysis of soluble and
insoluble fractions of PRPF31-GFP and A216P-GFP transfected ARPE-19 cells and co-transfected with WT PRPF31 tagged to Flag showed a
decrease in the concentration of WT PRPF31-Flag in the detergent-soluble fraction and an increase in the detergent-insoluble fraction of the cells
co-expressing the mutant A216P-GFP protein. Anti-GAPDH antibody was used as loading control (o). Scale bars (a-f) represent 25 μm and
(g-l) 10 μm
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phenotype in humans but also a phenotype with an early
macular degeneration. Similar results have been ob-
served with mutations in another gene such as RDS,
which encodes the photoreceptor glycoprotein periph-
erin. Mutations in RDS can produce both a clear RP
phenotype and also macular dystrophy (Wells et al.,
1993). Although no single nucleotide polymorphism in
PRPF31 gene has been described in AMD, it has been
suggested that alterations in normal mRNA splicing
could contribute to the pathophysiology of age-related
diseases such as AMD (Li et al., 2017). In the Prpf31
mutant mice, we observed that the splicing of several
genes is compromised. Among these genes, the ABCA4
gene stands out. ABCA4 is a gene expressed mainly in
photoreceptors but also RPE having a major function in
retinol metabolism (Lenis et al., 2018). Mutations in this
gene have been found to cause Stargardt’s disease, a her-
editary juvenile macular degeneration, and AMD (Baum
et al., 2003). Besides, it has been reported that ABCA4
splicing can be also affected by aging and in AMD cases
(Li et al., 2017; Baum et al., 2003; Meshorer & Soreq,
2002). For these reasons, we suggest that primary RPE
degeneration phenotype with drusen-like deposits
present in these Prpf31 mutant mice could be due to
splicing defects in genes that could be associated with
macular degenerative diseases such as ABCA4.
Fig. 7 Overexpression of A216P-GFP induces HSP70 activation in ARPE-19 cells. Immunostaining of cultured ARPE-19 cells transfected with
PRPF31-GFP (a-d) orA216P-GFP (e-h) displays PRPF31 aggregation in the cytoplasm of the cells overexpressing A216P-GFP (green) and
colocalization of HSP70 (red) in the aggregates (e-h). Images correspond to a maximum projection of a Z-stack. Western blot analysis (i) and
densitometry quantification (j) of the soluble and insoluble fraction of the transfected cells showing an increment of HSP70 concentration in the
detergent-insoluble fraction of the cells transfected with A216P-GFP. Anti-γ-tubulin antibody was used as loading control (i). The boxplot j
represents the ratio HSP70/γ-tubulin in soluble and insoluble fraction of PRPF31-GFP and A216P-GFP transfected ARPE-19 cells (n = 3 in each
group). Statistically significant differences were determined by Mann-Whitney U-test (*p < 0.05). Scale bars represent 10 μm
Valdés-Sánchez et al. Molecular Medicine            (2020) 26:1 Page 16 of 22
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It is known that the RPE maintains structural integrity
and function of photoreceptor cells and defends the ret-
ina from free radicals and photo-oxidative damage (Simo
et al., 2010; Strauss, 2005). A failure in any of the RPE
roles might induce retinal degeneration and loss of vis-
ual function. Two classical examples of RP due to muta-
tions in RPE-specific genes are MERTK and RPE65,
which cause RP (Gal et al., 2000) and Leber’s congenital
amaurosis (Gu et al., 1997), respectively. Thus, p.A216P
PRPF31 mutation might affect photoreceptors due to a
primary defect in the RPE as MERTK or RPE65 muta-
tions do.
As stated before, in humans, mutations in PRPF31 are
associated with photoreceptor-cell degeneration and
loss. The reason why Prpf31A216P/+ mice have RPE-
degeneration rather than photoreceptor-cell loss is not
clear, but we have found that gene expression level for
Prpf31 and the corresponding protein amount is much
higher in the RPE than in the neuroretina, although the
nuclei in the neuroretina greatly outnumber the nuclei
in the RPE monolayer. This was also observed in mouse,
pig, cow and human samples. Yuan and co-workers have
studied the expression of Prpf31 in different mouse tis-
sues including the retina (Yuan et al., 2005). Although
no differences were observed either in the expression
level or pattern of Prpf31 protein among different tis-
sues, they did not separate the neuroretina from the RPE
as we have done in this study and in fact, their in situ
hybridization results clearly show a much higher expres-
sion of Prpf31 in the RPE layer. The differential expres-
sion of Prpf31 could give us clues to understand why the
RPE specifically degenerates in these mice. The elevated
requirement of Prpf31 protein level in the RPE could be
related to high or specific splicing demands in an epithe-
lium that fulfils many different roles: light absorption,
transport of ions, water, and metabolic end-products
from the subretinal space to blood, maintenance of pho-
toreceptors and re-isomerization of all-trans-retinal into
11-cis-retinal. Thus, defects in splicing might have a great
impact on the normal function and survival of RPE cells.
To explore the role of Prpf31 p.A216P mutation in the
RPE, the distribution pattern of the protein was analysed
by immunofluorescence staining of whole-mount RPE
samples and Western blot of cytosolic and nuclear frac-
tions from WT and Prpf31A216P/+ mutant mice. As
expected, we found Prpf31 preferentially localized in the
nucleus of RPE cells in WT mice, although it was also
possible to observe a cytoplasmic fraction. On the other
hand, in the mutant mice almost no Prpf31 was found
within the nucleus, and most of the Prpf31 staining was
present in the cytoplasm forming rounded clumps of
Prpf31 protein resembling aggregates. The distribution
of RPE cells having Prpf31 aggregates was not uniform,
and we do not have an explanation for this finding.
Nevertheless, our results are in accordance with the ones
published by Deery and co-workers (Deery et al., 2002),
in which they found that overexpression of A194E and
A216P mutations in COS-7 cells induced mislocalization
of the mutant PRPF31 proteins, distributed throughout
the cytoplasm and with less intense staining in the nu-
cleus when compared with WT-PRPF31 transfected
cells. Also, Huranová and colleagues described similar
results overexpressing A216P in HeLa cells. They found
mislocalization of the mutant protein causing depletion
of PRPF31 from Cajal bodies, where splicing takes place,
and described a possible negative effect due to an abnor-
mal interaction of A216P with its partner, PRPF6 (Hura-
nova et al., 2009). It is important to note, that the Prpf31
protein detected in these mice corresponds to the en-
dogenous WT and mutant forms of the protein. Thus,
the aggregation that is found in the RPE of these mutant
mice is not an artefact resulting from Prpf31 overexpres-
sion. In Prpf31A216P/+ mice, aggregation of the mutant
protein completely depletes Prpf31 protein in the nu-
cleus and, in this way, a combination of a dominant-
negative effect and haploinsufficiency might contribute
to RPE degeneration.
Although the exact mechanism underlying RPE degen-
eration in the mutant mice is not well understood yet,
our transcriptomic analysis show that 1.6% of evaluated
genes are differentially expressed in the mutant RPE
when compared to WT controls. As expected, alterna-
tive splicing was also affected in the RPE of these mutant
mice. Around 11% of evaluated genes have, at least, one
differentially expressed probe selection region or junc-
tion, indicative of alternative splicing. From the pool of
affected genes, we selected Hspa4l for a detailed study, a
member of the HSP70 family of chaperons that was up-
regulated in the mutant RPE. The HSP70 family is a ubi-
quitous and conserved family of molecular chaperons,
(See figure on previous page.)
Fig. 8 Mobility of PRPF31 protein to the nucleus is affected by the p.A216P mutation. ARPE-19 cells transfected with the pEGFP-N1 plasmid alone
or carrying the open reading frame of human WT PRPF31 (PRPF31-GFP) or carrying the point mutation p.A216P (A216P-GFP) were imaged − 3 s
pre-photobleaching (a, e, i) and 0 s (b, f, j), 100 s (c, g, k) and 200 s (d, h, l) post-photobleaching. The recovery curve (m) indicates that the cells
transfected with mutant A216P-GFP have a smaller mf than those transfected with PRPF31-GFP (n). The boxplot n represents the normalized
fluorescence intensity and mobile fraction in PRPF31-GFP and A216P-GFP transfected ARPE-19 cells (n = 5 in each group). Statistically significant
differences were determined by Mann-Whitney U-test (*p < 0.05). Fi = fluorescence before bleaching, F0 = fluorescence just after bleaching, F∞ =
fluorescence in the bleached region after full recovery. Scale bars represent 10 μm
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part of the cellular machinery for protein folding that
prevents aggregation and protects cells from stress
(Mashaghi et al., 2016; Furukawa & Koriyama, 2016).
Several reports have shown that HSP70 and also small
heat shock proteins play an important role in retinal
dystrophies, including RP (Saliba et al., 2002), glaucoma
(Nagashima et al., 2011; Park et al., 2001; Schallenberg
et al., 2012) and AMD (Alge et al., 2002; Lee et al., 2011;
Nakata et al., 2005). Our qPCR analysis showed in-
creased expression of Hspa4l in the mutant RPE when
compared with its WT control. We further confirmed
this finding by Western blot analysis depicting a higher
amount of protein in the mutant RPE. Moreover, im-
munofluorescence staining showed colocalization of
Hspa4l signal with aggregates of Prpf31 protein in the
RPE cytoplasm of mutant mice. This suggests that
Hspa4l can be acting as a chaperone for the mutant pro-
tein in response to its aggregation. However, the aggre-
gation of Prpf31 in the RPE of mutant mice could also
activate other chaperones belonging to the family of
small heat shock proteins such as Hsp27.
In addition, several other genes and signalling path-
ways were found to have an altered splicing in the
RPE of mutant mice, including those associated with
inflammation, oxidative stress, retinol metabolism and
cellular apoptosis Most of these pathways are com-
monly affected in RPE degenerative diseases such as
AMD and mutations of some genes including in this
pathways such as ABCA4 cause macular degeneration
(Lenis et al., 2018; Makarev et al., 2014). In line with
these results, our histological findings in the mutant
RPE correlate with some macular degenerative fea-
tures. Apart from that, another group of genes af-
fected by the A216P mutation in RPE are involved in
ciliogenesis. This result is in agreement with the most
recent results of Buskin and co-workers in which they
show that iPS-derived RPE cells from RP11 patients
present shorter Mv and primary cilia, loss of polarity,
reduced barrier function and defective phagocytic cap-
acity, when compared to iPS-derived RPE cells from
healthy donors, suggesting that these distorted cellular
characteristics result from alternative splicing in RP11
(Buskin et al., 2018). We observed that one group of
proteins affected by differential splicing in
Prpf31A216P/+ mice are some splicing factors, including
Prpf31. Four main causes are known to induce pro-
tein aggregation: mutations, errors in protein synthe-
sis including splicing defects, environmental factors
such as oxidative stress and aging. Therefore, if the
Prpf31-protein level in the RPE nucleus is beneath its
threshold for normal function, the mRNA splicing of
Prpf31 gene could be affected producing an aberrant
protein prone to aggregation, reinforcing the
dominant-negative effect and haploinsufficiency.
To explore the role of Hsp70 family in the RPE affected
by a p.A216P mutation, we overexpressed both WT
PRPF31 and mutant A216P tagged to GFP in a human-
derived RPE cell line (ARPE-19). Immunofluorescence
staining results are in line with the in vivo results, with
WT PRPF31-GFP protein being located mainly in the nu-
cleus, and mutant A216P-GFP protein being mostly aggre-
gated in the cytoplasm. By Western blot analysis we found
that cells overexpressing the mutant variant have a signifi-
cant decrease in the soluble fraction of PRPF31 and an in-
crease in the insoluble PRPF31 protein. Moreover, the
overexpression of the mutant protein leads to a depletion
of the soluble endogenous PRPF31 protein and WT
PRPF31 tagged to Flag as well, suggesting a dominant-
negative effect. These results are in accordance with one
of the mechanisms proposed by Yin and coworkers in
which they report that mutations in PRPF31 can induce
retinal degeneration (Yin et al., 2011). They proposed
three mechanisms: i) haploinsufficiency due to loss of
function of the mutant protein or degradation of mutant
mRNA by nonsense-mediated mRNA decay, thus com-
promising the splicing machinery; ii) mutant proteins with
dominant-negative activity that may interfere with splicing
and potentially with other cellular activities, leading to de-
generation of the affected tissue; and iii) mutations might
promote proteins forming insoluble and cytotoxic aggre-
gates that can affect the tissue by loss-of-function and
dominant-negative effects (Yin et al., 2011). We also ob-
served that Hsp70 was upregulated in the cells overex-
pressing A216P-GFP and colocalized with PRPF31 mutant
protein. These results corroborate our in vivo findings of
Hspa4l upregulation in the RPE of Prpf31A216P/+ mice and
its colocalization with PRPF31 protein aggregates.
Considering that PRPF31 plays its role in the nucleus
and p.A216P induces PRPF31 aggregation in the cyto-
plasm of RPE cells, we decided to analyze how PRPF31
translocation to the nucleus was affected using FRAP
assay. PRPF31 contains a classical nuclear localization se-
quence (NLS) between residues 351 and 364. In a previous
study published by Wilkie, et al. (Wilkie et al., 2006) dem-
onstrated that p.A216P mutations did no affect the inter-
action with importin β1. However, FRAP studies in the
green monkey kidney fibroblast-like COS-7 cells of WT
PRPF31-GFP and mutant A216P-GFP transfected cells in-
dicated the presence of two-component recovery pro-
cesses, a fast component for free diffusion within an
unbounded compartment and a slow component for pas-
sive diffusion through the nuclear pores. The kinetics of
both components were not affected by the p.A216P muta-
tion (Wilkie et al., 2006). Therefore, seems that the muta-
tion p.A216P did not affect the NLS and its interaction
with importin β1 but the total amount of nuclear PRPF31
is affected probably because there is lest amount of cyto-
plasmic PRPF31 that can cross the nuclear pores through
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passive diffusion. We conclude in our FRAP experiments
that p.A216P mutation decreases the amount of PRPF31
protein that moves to the nucleus but without affecting
the diffusion time. We found that translocation of mf of
PRPF31 to the nucleus significantly decreases in ARPE-19
cells transfected with A216P-GFP. Our results are partially
in line with the studies by Wilkie and co-workers who
showed a similar FRAP pattern in COS-7 cells, although
they could not find a statistically significant delay in mu-
tant protein translocation to the nucleus when compared
with the WT protein (Wilkie et al., 2006). This can be an
artifact caused by the cell line, since it has been shown
that impaired splicing due to PRPF31 mutations is limited
to retinal cells (Buskin et al., 2018). These authors have re-
ported that alternative spliced transcripts due to RP11 are
only present in retina and RPE of the Prpf31+/− mutant
mice but not in other tissues such as brain or muscle sug-
gesting that a specific and highly regulated splicing pro-
gram takes place in the retinal cells. One of the most
interesting findings of these authors (Buskin et al., 2018)
with respect to our study is the fact that some alternatively
spliced forms of PRPF31 were found in RPE but not in the
neuroretina of the mutant KO mouse, supporting our
finding that lack of PRPF31 in the nuclei of RPE cells
could affect its own splicing.
Conclusion
Our findings of a substantial higher amount of PRPF31
in the RPE compared to the neuroretina, exhibiting a de-
generative phenotype of the RPE with drusen-like de-
posits, correlates with the growing amount of data
supporting a specific splicing program in retinal cell
types that is severely distorted by PRPF31 mutations.
Our results suggest that p.A216P mutation promotes a
damaging alternative splicing of PRPF31, generating a
dominant-negative effect in which aberrant splicing of
other genes and PRPF31 mutated protein aggregation
are involved. Depletion of functional PRPF31 protein
from the nucleus will also contribute to deficient spli-
cing, thus mixing haploinsufficiency with a dominant-
negative effect. In response to protein aggregation of
PRPF31, HSPA4L chaperon is activated and recruited to
the aggregates, to fold the aggregated protein and facili-
tate its translocation to the nucleus. A pharmacological
or genetic modulation of HSP70 family of proteins could
be a promising therapeutic target for RP caused by
PRPF31 mutations.
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Additional file 1: Figure S1. TEM images of RPE of 8-month-old WT (a)
and Prpf31A216P/+ mice (b). Photoreceptor outer segments (OS) were
observed in contact with the RPE microvilli (Mv) in WT mice (a). In
Prpf31A216P/+ mice OS and Mv are also observed; however, they looked
shorter and disorganized (b). RPE nuclei (Nu), melanin granules (Me),
basal infoldings (BI), Bruch’s membrane (BM) and choroid (Co) are also
displayed. Scale bars represent 5 μm. Figure S2. ERG recordings of WT
and Prpf31A216P/+ mice. Rod response and quantification of b-wave ampli-
tude in dark adapted mice (a-a”). Cone-rod response and quantification
of a-wave in dark adapted mice (b-b”). Cone response and quantification
of b-wave in light adapted mice (c-c”). RPE response and quantification
of c-wave in dark adapted mice (d-d”). The boxplots a”-d” represent the
a, b and c-wave amplitude in dark or light adapted WT and Prpf31A216P/+
mice (n = 6 in each group). Statistically significant differences were deter-
mined by Mann-Whitney U-test (*p < 0.05). Vertical scale bars represent
300 μV. Horizontal scale bars represent 100 ms (a-c’) and 1 s (d-d’). Figure
S3. Western blot analyses of PRPF31 expression in the neuroretina and
RPE of C57BL/6 mice, pig, cow and human samples. The amount of
PRPF31 protein is higher in the RPE than in the neuroretina in all the
cases. Anti-γ-tubulin antibody was used as loading control. Figure S4.
Whole-mount of the RPE obtained from WT (a-i) and Prpf31A216P/+ mice
(j-l). Negative controls of RPE autofluorescence (a-c) and secondary anti-
bodies nonspecific bindings are shown (d-f). The RPE of WT Prpf31A216P/+
mice were immunostained with anti-Prpf31 (g, j) and anti-Hsp27 anti-
bodies (h, k). TRITC-phalloidin was used to stain F-actin microfilaments
(a-l; blue). Merged images are shown (c, f, i, l). Prpf31 protein aggregates
were observed in the cytoplasm colocalizing with Hsp27 signal in mutant
Prpf31A216P/+ mice (j-l). Z-stack of a ARPE-19 cell transfected with PRPF31-
GFP (m-o). In the Z-stacks is possible to observe that PRPF31-GFP signal is
in the nucleus and not in the top of the nucleus. Scale bars represent
25 μm. Table S1. Gene ontology of differentially expressed genes in
Prpf31A216P/+ mice. The top 20 terms of 84 are listed. Table S2. Candi-
date genes differentially expressed in the RPE of Prpf31A216P/+ vs WT
mice. Default filter criteria, fold change < -2 or > 2 and p-value < 0.05.
Table S3. Functional categories of genes having alternative splicing in
Prpf31A216P/+ mice. The top 40 terms of 174 are listed. Table S4. Num-
ber of candidate genes showing alternative splicing in the RPE of
Prpf31A216P/+ vs WT mice. Default filter criteria, splicing index < -2 or > 2
and ANOVA p value < 0.05.
Additional file 2. Results of transcriptome array (MTA) 1.0 to evaluate
differential gene expression in RPE samples of six Prpf31A216P/+ and three
WT-littermates.
Additional file 3. Results of alternative splicing analysis (MTA) 1.0 in RPE
samples of six Prpf31A216P/+ and three WT-littermates.
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